Diana Rose Ranoa

Title: Innovations by Diana Rose Ranoa

Introduction

Diana Rose Ranoa is an accomplished inventor based in Champaign, Illinois. She has made significant contributions to the field of molecular testing, particularly in the context of public health. With two patents to her name, her work is paving the way for more accessible and efficient testing methods.

Latest Patents

One of her notable patents is a saliva-based molecular testing method for SARS-CoV-2. This innovative approach bypasses the need for RNA isolation and purification, making the testing process simpler and more efficient. In experiments involving inactivated SARS-CoV-2 virus spiked into saliva, this method demonstrated a limit of detection of 500-1000 viral particles per mL, which rivals the standard nasopharyngeal swab method. Initial studies showed excellent performance with 100 clinical samples, indicating its reliability. This saliva-based process is operationally simple, utilizes readily available materials, and can be easily implemented by existing testing sites. As a result, it allows for high-throughput, rapid, and repeat testing of large populations.

Career Highlights

Diana is affiliated with the University of Illinois, where she continues to advance her research and innovations. Her work is crucial in addressing the challenges posed by infectious diseases, particularly in the context of the COVID-19 pandemic.

Collaborations

Diana collaborates with esteemed colleagues, including Robin L Holland and Fadi G Alnaji. Their combined expertise enhances the impact of her research and contributes to the development of effective testing solutions.

Conclusion

Diana Rose Ranoa's contributions to molecular testing represent a significant advancement in public health. Her innovative saliva-based testing method for SARS-CoV-2 exemplifies her commitment to improving healthcare accessibility and efficiency.